zileuton has been researched along with Innate Inflammatory Response in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (31.58) | 18.2507 |
2000's | 9 (23.68) | 29.6817 |
2010's | 15 (39.47) | 24.3611 |
2020's | 2 (5.26) | 2.80 |
Authors | Studies |
---|---|
Kreft, AF; Musser, JH | 1 |
Brideau, C; Chan, CC; Delorme, D; Desmarais, S; Dubé, D; Ducharme, Y; Ethier, D; Falgueyret, JP; Girard, Y; Grimm, E; Guay, J; Hamel, P; Jones, TR; Kwong, E; McAuliffe, M; McFarlane, CS; Piechuta, H; Riendeau, D; Roumi, M; Tagari, P; Young, RN | 1 |
Greiner, C; Koeberle, A; Schubert-Zsilavecz, M; Werz, O; Wurglics, M; Zettl, H | 1 |
Dai, Z; He, S; Lai, L; Li, K; Liu, Y; McClendon, CL; Meng, H; Shang, E; Zhang, X | 1 |
Ambruosi, M; Belardo, C; Collarile, S; de Rosa, M; Dehm, F; Esposito, V; Filosa, R; Guida, F; Krauth, V; Maione, S; Massa, A; Peduto, A; Werz, O | 1 |
Aidhen, IS; Doble, M; Ramanan, M; Sinha, S; Sudarshan, K | 1 |
Banoglu, E; Bruno, F; D'Amico, M; De Rosa, M; Errico, S; Filosa, R; Fiorentino, A; Guida, F; Maione, S; Maisto, R; Mkrtchyan, AS; Nawrozkij, MB; Olgaç, A; Pace, S; Werz, O | 1 |
Bilancia, R; Cantone, V; Cheung, SY; Esposito, L; Gerstmeier, J; Hanke, T; Koeberle, A; König, S; Liening, S; Pace, S; Rizza, R; Rossi, A; Roviezzo, F; Schubert-Zsilavecz, M; Schuster, D; Stuppner, H; Temml, V; Troisi, F; Werner, M; Werz, O | 1 |
Doble, M; Manju, SL; Sinha, S | 1 |
Abu-Serie, MM; AlFadly, ED; Bakkar, NZ; Bartolini, M; Belal, ASF; El-Yazbi, AF; Elkazaz, S; Elzahhar, PA; Ghareeb, DA; Iriepa, I; Janockova, J; Kobeissy, F; Moraleda, I; Rafeh, RW; Saudi, MNS; Shaltout, H; Soukup, O; Tramarin, A | 1 |
Bobál, P; Gazdová, M; Hošek, J; Jakubczyk, K; Landa, P; Leláková, V; Malaník, M; Oravec, M; Pailee, P; Pížová, H; Prachyawarakorn, V; Ren, G; Schuster, D; Šmejkal, K; Temml, V; Veselý, O; Zpurný, F | 1 |
Alsabil, K; Bernardes, GJL; Bilancia, R; Bréard, D; Brunner, E; Cerqua, I; Dinh, CP; Garscha, U; Gerstmeier, J; Gollowitzer, A; Helesbeux, JJ; Jordan, PM; Koeberle, A; Loeser, K; Lorkowski, S; Marques, MC; Mosig, AS; Neukirch, K; Pace, S; Permann, S; Raasch, M; Richomme, P; Rodrigues, T; Rossi, A; Roviezzo, F; Schuster, D; Séraphin, D; Stuppner, H; Temml, V; Viault, G; Ville, A; Werz, O | 1 |
Chen, H; Deng, Y; Guo, Z; He, Z; Liang, Y; Liu, L; Sun, X; Zhang, P; Zhang, Z | 1 |
Barrero, C; Li, JG; Merali, S; Praticò, D | 1 |
Akyol, O; Huang, L; McBride, DW; Sherchan, P; Wang, Y; Zhang, JH | 1 |
Domon, H; Isono, T; Kawabata, S; Kurosawa, M; Maekawa, T; Oda, M; Terao, Y; Yamaguchi, M | 1 |
Bujalska-Zadrozny, M; Gasinska, E; Maslinski, S; Rzodkiewicz, P | 1 |
Chen, CM; Liang, RS; Shi, SS; Tu, XK; Wang, CH; Yang, WZ; Zhang, HB | 1 |
Anderson, GD; Cortes-Burgos, LA; Graneto, MJ; Happa, FA; Hardy, MM; Hu, G; Masferrer, JL; Muthian, S; Pufahl, RA; Settle, SL; Stewart, Z; Weir, DE; Zweifel, BS | 1 |
Amghar, H; Bouloumié, A; Bourlier, V; Féral, CC; Filloux, C; Galitzky, J; Grimaldi, PA; Mothe-Satney, I; Neels, JG; Pons, C; Van Obberghen, E | 1 |
da Silva, NG; Gonçalves, LR; Sampaio, SC | 1 |
Glori, M; Hintz, KH; Welliver, RC | 1 |
Britti, D; Chatterjee, PK; Cuzzocrea, S; Di Paola, R; Patel, NS; Sautebin, L; Thiemermann, C | 1 |
Kulkarni, SK; Patil, CS; Singh, VP | 1 |
Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Jiang, X; Karlsson, L; Lundeen, KA; Rao, NL; Riley, JP; Williams, KN; Xue, X | 1 |
Bramanti, P; Caminiti, R; Cuzzocrea, S; Di Paola, R; Genovese, T; Mazzon, E; Muià, C; Rossi, A; Sautebin, L | 1 |
Anderson, GD; Dufield, DR; Hardy, MM; Masferrer, JL; Pufahl, RA; Zweifel, BS | 1 |
Butler, BD; Little, T | 1 |
Bailie, MB; Carter, GW; Dahm, LJ; Harris, RR; Peters-Golden, M; Roth, RA | 1 |
Cohn, J; Kaminsky, DA; Martin, RJ; Trudeau, JB; Wenzel, SE; Westcott, JY | 1 |
Chabot-Fletcher, M; Chilton, FH; Fonteh, AN; Huang, L; Marshall, LA; Sung, CM; Winkler, JD | 1 |
Bell, RL; Brooks, DW; Carter, GW; Hansen, R; Lanni, C; Malo, PE; Rubin, P; Stewart, AO | 1 |
Medvedeff, ED; Nickerson-Nutter, CL | 1 |
Andresen, CJ; Eggler, JF; Smith, WB; Turner, CR; Watson, JW | 1 |
Smith, LJ | 1 |
Jackson, SK; Larsen, JS | 1 |
Drazen, JM | 1 |
Crawley, GC; Foster, SJ; McMillan, RM; Spruce, KE; Walker, ER | 1 |
5 review(s) available for zileuton and Innate Inflammatory Response
Article | Year |
---|---|
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Asthma; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases; Neutrophils; Quinolines | 1992 |
Inhibition of CoA-independent transacylase reduces inflammatory lipid mediators.
Topics: Acyltransferases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Humans; Hydroxyurea; Imidazoles; Inflammation; Mast Cells; Monocytes; Neutrophils; Organophosphorus Compounds | 1995 |
Leukotrienes in asthma. The potential therapeutic role of antileukotriene agents.
Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Humans; Hydroxyurea; Indoles; Inflammation; Inflammation Mediators; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Phenylcarbamates; Sulfonamides; Tosyl Compounds | 1996 |
Antileukotriene therapy for asthma.
Topics: Asthma; Humans; Hydroxyurea; Inflammation; Leukotrienes; Lipoxygenase Inhibitors | 1996 |
New directions in asthma drug therapy.
Topics: Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Chromones; Humans; Hydroxyurea; Indoles; Inflammation; Leukotrienes; Lipoxygenase Inhibitors; Phenylcarbamates; Sulfonamides; Tosyl Compounds | 1998 |
1 trial(s) available for zileuton and Innate Inflammatory Response
Article | Year |
---|---|
Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma.
Topics: Adolescent; Adult; Asthma; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Cross-Over Studies; Double-Blind Method; Forced Expiratory Volume; Humans; Hydroxyurea; Inflammation; Leukotriene E4; Leukotrienes; Lipoxygenase Inhibitors; Middle Aged | 1995 |
32 other study(ies) available for zileuton and Innate Inflammatory Response
Article | Year |
---|---|
Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics of L-739,010.
Topics: Animals; Ascaris; Biological Availability; Bronchodilator Agents; Dogs; Dyspnea; Humans; Inflammation; Lipoxygenase Inhibitors; Magnetic Resonance Spectroscopy; Male; Molecular Conformation; Molecular Structure; Naphthalenes; Nematode Infections; Pyridines; Rats; Recombinant Proteins; Saimiri; Sheep; Spodoptera; Transfection | 1997 |
Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
Topics: Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Cyclooxygenase 1; Cyclooxygenase 2; Drug Design; Enzyme Activation; Enzyme Inhibitors; Humans; Inflammation; Inhibitory Concentration 50; Intramolecular Oxidoreductases; Lipoxygenase Inhibitors; Models, Chemical; Prostaglandin-E Synthases; Pyrimidines | 2008 |
Discovery of Novel 15-Lipoxygenase Activators To Shift the Human Arachidonic Acid Metabolic Network toward Inflammation Resolution.
Topics: Allosteric Site; Arachidonate 15-Lipoxygenase; Arachidonic Acid; Cell-Free System; Cyclooxygenase Inhibitors; Drug Discovery; Humans; Inflammation; Lipoxygenase Inhibitors | 2016 |
Exploring the role of chloro and methyl substitutions in 2-phenylthiomethyl-benzoindole derivatives for 5-LOX enzyme inhibition.
Topics: Adult; Animals; Arachidonate 5-Lipoxygenase; Carrageenan; Dose-Response Relationship, Drug; Edema; Humans; Indoles; Inflammation; Lipoxygenase Inhibitors; Mice; Molecular Structure; Neutrophils; Structure-Activity Relationship | 2016 |
Inhibition of the enzymes in the leukotriene and prostaglandin pathways in inflammation by 3-aryl isocoumarins.
Topics: Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cytokines; Dinoprostone; Free Radicals; Gene Expression Regulation, Enzymologic; HeLa Cells; Humans; Inflammation; Isocoumarins; Kinetics; Leukotrienes; Lipoxygenase Inhibitors; Prostaglandins; RNA, Messenger | 2016 |
Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO/m-PGES-1 dual inhibitors able to suppress inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Carrageenan; Dose-Response Relationship, Drug; Edema; Humans; Indoles; Inflammation; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred ICR; Molecular Structure; Neutrophils; Prostaglandin-E Synthases; Structure-Activity Relationship | 2018 |
Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Benzenesulfonamides; Cells, Cultured; HEK293 Cells; Humans; Inflammation; Lipoxygenase Inhibitors; Macrophages; Male; Mice; Molecular Docking Simulation; Prostaglandin-E Synthases; Sulfonamides | 2018 |
Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase.
Topics: Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Drug Design; Humans; Inflammation; Lipoxygenase Inhibitors; Molecular Docking Simulation; Structure-Activity Relationship; Thiazoles | 2018 |
Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase.
Topics: Acetylcholine; Alzheimer Disease; Animals; Cell Line; Cholinesterase Inhibitors; Cyclooxygenase 2 Inhibitors; Drug Design; Humans; Inflammation; Lipoxygenase Inhibitors; Mice; Molecular Docking Simulation; Neurons; PC12 Cells; Rats; Semicarbazides; Triazoles | 2019 |
Prenylated Stilbenoids Affect Inflammation by Inhibiting the NF-κB/AP-1 Signaling Pathway and Cyclooxygenases and Lipoxygenase.
Topics: Cell Line; Enzyme Inhibitors; Humans; Inflammation; Lipoxygenases; NF-kappa B; Prenylation; Prostaglandin-Endoperoxide Synthases; Signal Transduction; Stilbenes; Transcription Factor AP-1 | 2019 |
Exploration of Long-Chain Vitamin E Metabolites for the Discovery of a Highly Potent, Orally Effective, and Metabolically Stable 5-LOX Inhibitor that Limits Inflammation.
Topics: Administration, Oral; Arachidonate 5-Lipoxygenase; Dose-Response Relationship, Drug; Drug Discovery; Humans; Inflammation; Lipoxygenase Inhibitors; Molecular Docking Simulation; Molecular Structure; Recombinant Proteins; Structure-Activity Relationship; Vitamin E | 2021 |
5-Lipoxygenase inhibition reduces inflammation and neuronal apoptosis via AKT signaling after subarachnoid hemorrhage in rats.
Topics: Administration, Oral; Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Brain Injuries; Chromones; Disease Models, Animal; Humans; Hydroxyurea; Inflammation; Infusions, Intraventricular; Lipoxygenase Inhibitors; Male; Morpholines; Neurons; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Subarachnoid Hemorrhage | 2021 |
Five lipoxygenase hypomethylation mediates the homocysteine effect on Alzheimer's phenotype.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Behavior, Animal; Diet; DNA Methylation; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hydroxyurea; Inflammation; Lipoxygenase; Male; Mice, Transgenic; Phenotype; Phosphorylation; Synapses; tau Proteins; Up-Regulation; Vitamin B Complex; Vitamin B Deficiency | 2017 |
Naja sputatrix Venom Preconditioning Attenuates Neuroinflammation in a Rat Model of Surgical Brain Injury via PLA2/5-LOX/LTB4 Cascade Activation.
Topics: Animals; Arachidonate 5-Lipoxygenase; Biomarkers; Brain; Brain Edema; Brain Injuries; Elapid Venoms; Hydroxyurea; Inflammation; Intraoperative Complications; Leukocyte Count; Leukotriene B4; Lipoxygenase Inhibitors; Naja; Phospholipase A2 Inhibitors; Phospholipases A2; Rats; Signal Transduction; Skin; Subcutaneous Tissue; Terpenes | 2017 |
Topics: Animals; Aorta; Arachidonic Acid; Aspirin; Cell Adhesion Molecules; DNA, Bacterial; Endothelial Cells; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Hydroxyurea; Inflammation; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred BALB C; Monocytes; Mutation; Phospholipases A2; Recombinant Proteins; Signal Transduction; Streptococcus pyogenes; THP-1 Cells; Vascular Cell Adhesion Molecule-1 | 2017 |
Antinociceptive properties of esculetin in non-inflammatory and inflammatory models of pain in rats.
Topics: Analgesia; Analgesics; Animals; Arachidonate 5-Lipoxygenase; Disease Models, Animal; Hydroxyurea; Hyperalgesia; Inflammation; Leukotriene B4; Lipoxygenase Inhibitors; Male; Pain; Pain Threshold; Rats; Umbelliferones | 2015 |
5-LOX Inhibitor Zileuton Reduces Inflammatory Reaction and Ischemic Brain Damage Through the Activation of PI3K/Akt Signaling Pathway.
Topics: Animals; Arachidonate 5-Lipoxygenase; Brain; Brain Ischemia; Hydroxyurea; Infarction, Middle Cerebral Artery; Inflammation; Lipoxygenase Inhibitors; Male; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction | 2016 |
CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain.
Topics: Administration, Oral; Animals; Arachidonate 5-Lipoxygenase; Blotting, Western; Cell Line; Disease Models, Animal; Enzyme Inhibitors; Freund's Adjuvant; Humans; Hydroxyurea; Imidazoles; Immunohistochemistry; Inflammation; Leukotrienes; Lipoxygenase Inhibitors; Male; Osteoarthritis; Pain; Rats; Rats, Sprague-Dawley; Substrate Specificity; Sulfides | 2009 |
Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice.
Topics: Adipocytes; Adipose Tissue; Animals; Arachidonate 5-Lipoxygenase; Cell Line; Chemokines; Cytokines; Diet, High-Fat; Female; Humans; Hydroxyurea; Inflammation; Insulin Resistance; Leukotrienes; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred C57BL; Obesity; Subcutaneous Fat | 2012 |
Inhibitory effect of Crotalus durissus terrificus venom on chronic edema induced by injection of bacillus Calmette-Guérin into the footpad of mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; BCG Vaccine; Chronic Disease; Crotalid Venoms; Crotalus; Crotoxin; Dexamethasone; Edema; Foot; Hindlimb; Hydroxyurea; Inflammation; Injections, Subcutaneous; Lipoxygenase; Male; Mice; Mycobacterium bovis | 2013 |
Zileuton reduces respiratory illness and lung inflammation, during respiratory syncytial virus infection, in mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Count; Disease Models, Animal; Hydroxyurea; Inflammation; Leukotriene Antagonists; Leukotrienes; Lung; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Time Factors; Virus Replication; Weight Loss | 2003 |
Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.
Topics: Animals; Arachidonate 5-Lipoxygenase; Disease Models, Animal; Hydroxyurea; Inflammation; Intercellular Adhesion Molecule-1; Ischemia; Kidney Diseases; Leukotriene B4; Lipoxygenase Inhibitors; Mice; Mice, Knockout; Neutrophils; Peroxidase; Reperfusion Injury | 2004 |
Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats.
Topics: Acetates; Acetic Acid; Analgesics; Animals; Capillary Permeability; Carrageenan; Cyclopropanes; Dose-Response Relationship, Drug; Female; Hindlimb; Hydroxyurea; Hyperalgesia; Indoles; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Mice; Pain; Pain Measurement; Phenylcarbamates; Quinolines; Rats; Rats, Wistar; Receptors, Leukotriene B4; Sulfides; Sulfonamides; Tosyl Compounds | 2005 |
Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Ascitic Fluid; Benzothiazoles; Dogs; Ear; Edema; Eicosanoids; Enzyme Inhibitors; Epoxide Hydrolases; Female; Humans; Hydroxyurea; Inflammation; Leukotriene B4; Leukotriene C4; Lipoxins; Lipoxygenase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Neutrophil Infiltration; Peritonitis; Piperidines; Recombinant Proteins | 2007 |
Effects of zileuton and montelukast in mouse experimental spinal cord injury.
Topics: Acetates; Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Cyclooxygenase 2; Cyclopropanes; Cysteine; Dinoprostone; Disease Models, Animal; Gene Expression Regulation; Hydroxyurea; Inflammation; Leukotrienes; Lipoxygenase Inhibitors; Male; Mice; Neutrophil Infiltration; Quinolines; Recovery of Function; Spinal Cord Injuries; Sulfides; Tumor Necrosis Factor-alpha | 2008 |
A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
Topics: Air; Animals; Arachidonate 5-Lipoxygenase; Biological Assay; Calcimycin; Carrageenan; Cell Line, Tumor; Chromatography, Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Enzyme-Linked Immunosorbent Assay; Humans; Hydroxyurea; Imidazoles; Immunoglobulin E; Inflammation; Ionophores; Leukotrienes; Lipoxygenase Inhibitors; Male; Mast Cells; Oxidation-Reduction; Rats; Rats, Inbred Lew; Reproducibility of Results; Sulfides; Tandem Mass Spectrometry | 2008 |
Pharmacological intervention to the inflammatory response from decompression sickness in rats.
Topics: Animals; Cyclooxygenase Inhibitors; Decompression Sickness; Hydroxyurea; Indoles; Indomethacin; Inflammation; Isoproterenol; Lipoxygenase Inhibitors; Lysine; Male; Phenylcarbamates; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Sulfonamides; Tosyl Compounds | 2008 |
Leukotrienes and alpha-naphthylisothiocyanate-induced liver injury.
Topics: 1-Naphthylisothiocyanate; Acetamides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcimycin; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Glutathione; Hydroxyurea; Indoles; Inflammation; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Liver; Liver Diseases; Male; Phenyl Ethers; Rats; Rats, Sprague-Dawley | 1995 |
Preclinical and clinical activity of zileuton and A-78773.
Topics: Animals; Bronchial Spasm; Guinea Pigs; Hydroxyurea; Inflammation; Leukotriene B4; Lipoxygenase Inhibitors; Lung; Male; Rats | 1993 |
The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Chronic Disease; Disease Models, Animal; Drug Combinations; Exudates and Transudates; Female; Hydroxyurea; Inflammation; Leukotriene B4; Lipoxygenase; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Naproxen; Prostaglandin-Endoperoxide Synthases; Quinolines; Time Factors; Zymosan | 1996 |
The effect of 5-lipoxygenase inhibition on Ascaris antigen (Ag)-induced responses in atopic monkeys.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Helminth; Ascaris suum; Bronchoalveolar Lavage Fluid; Hydroxyurea; Inflammation; Leukocyte Count; Lipoxygenase Inhibitors; Macaca fascicularis; Male; Neutrophils; Pyrans; Quinolones | 1996 |
Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Bronchoconstriction; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Guinea Pigs; Hydroxyurea; Inflammation; Knee Joint; Leukotriene B4; Lipoxygenase Inhibitors; Macrophages; Male; Mice; Oxidation-Reduction; Pyrans; Quinolones; Rabbits; Rats; Thromboxane B2 | 1992 |